IP Verse

Baxter International Inc. competitive analysis

Latest oppositions filed by Baxter International Inc.

Explore patent oppositions filed by Baxter International Inc. against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 15, 2026
Patent NumberTitleApplicantOpposition Date
EP4175602
Patient Handling ApparatusARJO HOLDING AKTIEBOLAGJul 2, 2025
EP3790600
Method For Preparing A Haemostatic CompositionETHICONSep 27, 2024
EP3370783
Compacted Hemostatic Cellulosic AggregatesCILAGMar 7, 2024
EP3466455
Oxidized Regenerated Cellulose Hemostatic Powders And Methods Of MakingETHICONOct 19, 2022
EP2854882
Oxidized Regenerated Cellulose Hemostatic Powders And Methods Of MakingETHICONJul 31, 2019
EP3019205
Hemostatic Pad Assembly Kit And MethodETHICONJul 4, 2018
EP2726115
Procoagulant Peptides And Their Derivatives And Uses ThereforETHICONJun 13, 2018
EP2638194
A Resorbable Laparoscopically Deployable HemostatETHICONMay 30, 2018
EP1663297
Hemostatic Compositions Containing Sterile ThrombinETHICONDec 22, 2017
EP2654863
Powder Delivery DevicePROFIBRIXJun 2, 2017

Latest patents of Baxter International Inc. opposed by its competitors

Explore Baxter International Inc.'s recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 15, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP2939697
Jul 16, 2025Hemostatic Sponge1
EP4346839
Mar 26, 2025Pharmaceutical Compositions For Clinical Nutrition2
EP3703777
Jul 3, 2024Dextrose Concentrate For The Dialysate And For Disinfecting1
EP2273995
Nov 15, 2023Destruction Of Microbial Products By Enzymatic Digestion1
EP3773790
Oct 11, 2023Gravity Fed Dialysis Systems1
EP2227268
Aug 23, 2023Optimizing Clearance For Protein Bound Molecules Using Cascade Filtration Therapy1
EP2467399
Feb 1, 2023Purification Of Vwf For Increased Removal Of Non-Lipid Enveloped Viruses1
EP2324871
May 26, 2021Citrate Anticoagulation System For Extracorporeal Blood Treatments2
EP2318070
Jun 19, 2019Dialysis System Having Filtering Method For Determining Therapy Prescriptions1
EP2356247
May 15, 2019Method Of Producing Serum-Free Insulin-Free Factor Vii1

Latest PTAB cases involving Baxter International Inc.

Discover the latest PTAB cases involving Baxter International Inc., highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 19, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Baxter International Inc.

IPR2020-00024Oct 18, 2019BAXTERBECTONInstitution Denied
IPR2020-00025Oct 18, 2019BAXTERBECTONInstitution Denied
IPR2020-00026Oct 18, 2019BAXTERBECTONInstitution Denied
IPR2020-00026Oct 18, 2019BAXTERHOANGInstitution Denied
IPR2020-00027Oct 18, 2019BAXTERBECTONInstitution Denied
IPR2018-01741Sep 17, 2018BECTONBAXTERInstitution Denied
IPR2018-01742Sep 17, 2018BECTONBAXTERInstitution Denied
IPR2018-01744Sep 17, 2018BECTONBAXTERInstitution Denied
IPR2017-00202Nov 4, 2016CAREFUSIONBAXTERFinal Written Decision
IPR2016-01456Jul 19, 2016CAREFUSIONBAXTERInstitution Denied

Peer Comparison New

IP litigation analysis comparing Baxter International Inc. with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 15, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BAXTER1447515
BECTON712198
ETHICON1816914
FRESENIUS MEDICAL CARE544 - 2